These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34745261)

  • 1. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment.
    Liu F; Yu X; He G
    J Oncol; 2021; 2021():9987376. PubMed ID: 34745261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment.
    Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X
    Front Immunol; 2022; 13():888650. PubMed ID: 35572541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
    Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer.
    Dong M; Shen W; Yang G; Yang Z; Li X
    Front Cell Dev Biol; 2022; 10():785058. PubMed ID: 35178386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
    Luo Y; Sun X; Xiong J
    Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma.
    Xu H; Yin L; Xu Q; Xiang J; Xu R
    Cancer Cell Int; 2022 May; 22(1):199. PubMed ID: 35606813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
    Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
    Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of prognostic m6A modification patterns and score system in melanoma patients.
    Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y
    Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study.
    Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L
    Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620
    [No Abstract]   [Full Text] [Related]  

  • 13. M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy.
    Zhao K; Wei B; Zhang Y; Shi W; Zhang G; Wang Z
    Front Pharmacol; 2022; 13():1052177. PubMed ID: 36438800
    [No Abstract]   [Full Text] [Related]  

  • 14. m
    Liao K; Hu J; Huang Y; Yu S; Yang Q; Sun F; Wu C; Cheng Y; Zhang W; Zhang X; Li H; Wang X
    Front Oncol; 2022; 12():879405. PubMed ID: 35875124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
    Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer.
    Cai L; Liu T; Hua H; Jiang X; Qian L
    BMC Endocr Disord; 2023 Dec; 23(1):271. PubMed ID: 38057752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma.
    Wang G; Zeng D; Sweren E; Miao Y; Chen R; Chen J; Wang J; Liao W; Hu Z; Kang S; Garza LA
    J Invest Dermatol; 2023 Aug; 143(8):1579-1590.e5. PubMed ID: 36842525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
    Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
    Front Genet; 2021; 12():752025. PubMed ID: 35046996
    [No Abstract]   [Full Text] [Related]  

  • 19. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
    Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
    Front Immunol; 2021; 12():765723. PubMed ID: 35003079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.